Guideline adherence and long-term clinical outcomes in patients with acute myocardial infarction: a Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition (J-MINUET) substudy

Autor: Hideki Wada, Manabu Ogita, Satoru Suwa, Koichi Nakao, Yukio Ozaki, Kazuo Kimura, Junya Ako, Teruo Noguchi, Satoshi Yasuda, Kazuteru Fujimoto, Yasuharu Nakama, Takashi Morita, Wataru Shimizu, Yoshihiko Saito, Atsushi Hirohata, Yasuhiro Morita, Teruo Inoue, Atsunori Okamura, Toshiaki Mano, Kazuhito Hirata, Kengo Tanabe, Yoshisato Shibata, Mafumi Owa, Kenichi Tsujita, Hiroshi Funayama, Nobuaki Kokubu, Ken Kozuma, Shiro Uemura, Tetsuya Toubaru, Keijiro Saku, Shigeru Oshima, Kunihiro Nishimura, Yoshihiro Miyamoto, Hisao Ogawa, Masaharu Ishihara, Tadaya Sato, Hiroyuki Kyono, Tetsuya Tobaru, Takahito Sone, Yasuhiro Sone, Masashi Fujino, Kunihiko Nishimura, Junichi Kotani, Hiroyuki Okura, Masaaki Uematsu, Shirou Uemura, Seiji Hokimoto
Rok vydání: 2020
Předmět:
Cardiovascular event
Male
medicine.medical_specialty
Time Factors
medicine.medical_treatment
Treatment outcome
Adrenergic beta-Antagonists
Myocardial Infarction
030204 cardiovascular system & hematology
Critical Care and Intensive Care Medicine
Revascularization
Coronary Angiography
03 medical and health sciences
Electrocardiography
0302 clinical medicine
Japan
Internal medicine
medicine
Humans
In patient
030212 general & internal medicine
Myocardial infarction
Hospital Mortality
Prospective Studies
Registries
Aged
Aged
80 and over

Angiotensin Receptor Antagonists
Aspirin
business.industry
Guideline adherence
General Medicine
Middle Aged
medicine.disease
Prognosis
Clinical Practice
Survival Rate
Female
Guideline Adherence
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Morbidity
Cardiology and Cardiovascular Medicine
business
Platelet Aggregation Inhibitors
Follow-Up Studies
Zdroj: European heart journal. Acute cardiovascular care. 9(8)
ISSN: 2048-8734
Popis: Background: The association between guideline adherence and long-term outcomes in patients with acute myocardial infarction in real-world clinical practice remains unclear. Methods: We investigated 3283 consecutive patients with acute myocardial infarction who were selected from a prospective, nation-wide, multicentre registry (J-MINUET) database covering 28 institutions in Japan between July 2012 and March 2014. Among the 2757 eligible patients, we evaluated the use of seven guideline-recommended therapies, including urgent revascularisation, door-to-balloon time of 90 minutes or less, and five discharge medications (P2Y12 inhibitors on aspirin, beta-blockers, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, statins, lipid-lowering drugs). The primary endpoint was a composite of all-cause death, non-fatal myocardial infarction, non-fatal stroke, cardiac failure and urgent revascularisation for unstable angina up to 3 years. Results: The overall median composite guideline adherence was 85.7%. Patients were divided into the following three groups: complete (100%) adherence group (n=862); moderate adherence (75% to Conclusion: The use of guideline-based therapies for patients with acute myocardial infarction in contemporary clinical practice was associated with significant decreases in adverse long-term clinical outcomes. Trial registration: UMIN Unique trial Number: UMIN000010037
Databáze: OpenAIRE